Foxp3<sup>+</sup>CD25<sup>+</sup>CD4<sup>+</sup> natural regulatory T cells in dominant self‐tolerance and autoimmune disease

Immunological Reviews - Tập 212 Số 1 - Trang 8-27 - 2006
Shimon Sakaguchi1,2, Masahiro Ono2, Ruka Setoguchi2,3, Haruhiko Yagi2, Shohei Hori2,4, Zoltán Fehérvári2,5, Jun Shimizu6, Takeshi Takahashi2,7, Takashi Nomura2
1Core Research for Evolutional Science and Technology (CREST), Science and Technology Agency of Japan, Kawaguchi, Japan
2Department of Experimental Pathology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
3Present address: Department Immunology, University Washington, Seattle 98195, USA.
4Present address: Research Center for Allergy and Immunology, Institute for Physical and Chemical Research (RIKEN), Yokohama 230-0045, Japan.
5Present address: Department Pathology, Division Immunology, Cambridge University, Cambridge CB2 1QP, UK.
6National Center for Geriatrics and Gerontology, Ohbu, Japan
7Present address: Deutsches Rheumaforschungszentrum Berlin (DRFZ), 10117 Berlin, Germany.

Tóm tắt

Summary:  Naturally arising CD25+CD4+ regulatory T (Treg) cells, most of which are produced by the normal thymus as a functionally mature T‐cell subpopulation, play key roles in the maintenance of immunologic self‐tolerance and negative control of a variety of physiological and pathological immune responses. Natural Tregs specifically express Foxp3, a transcription factor that plays a critical role in their development and function. Complete depletion of Foxp3‐expressing natural Tregs, whether they are CD25+ or CD25, activates even weak or rare self‐reactive T‐cell clones, inducing severe and widespread autoimmune/inflammatory diseases. Natural Tregs are highly dependent on exogenously provided interleukin (IL)‐2 for their survival in the periphery. In addition to Foxp3 and IL‐2/IL‐2 receptor, deficiency or functional alteration of other molecules, expressed by T cells or non‐T cells, may affect the development/function of Tregs or self‐reactive T cells, or both, and consequently tip the peripheral balance between the two populations toward autoimmunity. Elucidation of the molecular and cellular basis of this Treg‐mediated active maintenance of self‐tolerance will facilitate both our understanding of the pathogenetic mechanism of autoimmune disease and the development of novel methods of autoimmune disease prevention and treatment via enhancing and re‐establishing Treg‐mediated dominant control over self‐reactive T cells.

Từ khóa


Tài liệu tham khảo

10.1146/annurev.immunol.21.120601.141122

10.1146/annurev.immunol.18.1.423

10.1038/ni0901-816

10.4049/jimmunol.155.3.1151

10.1034/j.1600-065X.2001.1820115.x

Itoh M, 1999, Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self‐tolerance, J Immunol, 162, 5317, 10.4049/jimmunol.162.9.5317

10.1016/S0167-5699(99)01559-5

10.1084/jem.20030152

10.1084/jem.20040249

10.1038/86302

10.1038/ni1318

10.1002/0470871628.ch2

10.1084/jem.20030686

10.1093/intimm/10.12.1969

10.1111/j.0105-2896.2006.00415.x

10.1038/ni1180

10.1126/science.1079490

10.1038/ni904

10.1038/ni909

10.1038/83784

10.1172/JCI11679

10.1038/83707

10.1038/83713

10.1093/intimm/dxh165

10.2337/diabetes.54.2.306

10.1038/sj.gt.3302567

10.1016/j.immuni.2005.01.016

10.1084/jem.20050157

10.1084/jem.20050784

10.1084/jem.184.2.387

10.1111/j.0105-2896.2005.00231.x

10.4049/jimmunol.165.6.3105

10.4049/jimmunol.176.8.4748

10.1002/eji.1830260125

10.1073/pnas.0404870101

Sakaguchi S, 2000, Role of genetic factors in organ‐specific autoimmune diseases induced by manipulating the thymus or T cells, and not self‐antigens, Rev Immunogenet, 2, 147

10.1016/j.amjcard.2004.01.060

10.1046/j.1365-2249.2002.01940.x

10.1210/jc.2003-031080

10.4049/jimmunol.172.10.5967

10.1136/jmg.39.8.537

Sakaguchi S, 1994, Autoimmunity: Physiology and Disease., 203

10.1016/j.exphem.2004.03.012

10.1182/blood-2004-10-4051

10.1038/352621a0

10.1111/j.1600-065X.1995.tb00092.x

10.1016/1074-7613(95)90180-9

10.1084/jem.190.11.1561

10.1073/pnas.94.7.3168

10.1038/ni1263

10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T

10.1016/S1074-7613(02)00367-9

10.4049/jimmunol.169.9.4850

10.1038/ni1264

10.4049/jimmunol.172.11.6519

10.1084/jem.20041982

10.1073/pnas.132254399

10.1016/j.coi.2003.09.013

10.1038/5941

10.1006/cyto.1999.0609

10.1016/j.coi.2005.09.013

10.1086/429843

10.4049/jimmunol.171.7.3435

10.4049/jimmunol.171.11.5853

Sakaguchi S, 1989, Organ‐specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease, J Immunol, 142, 471, 10.4049/jimmunol.142.2.471

10.1084/jem.158.1.1

10.1016/j.bbmt.2005.11.002

10.1016/j.it.2006.01.005

10.1084/jem.20050855

10.1084/jem.20030422

10.1084/jem.20040139

10.1093/intimm/dxh122

10.1084/jem.192.2.303

10.1084/jem.192.2.295

10.1016/S1074-7613(00)80195-8

10.1002/eji.200425143

10.1084/jem.187.3.427

10.4049/jimmunol.169.4.1852

10.1038/ni846

10.1038/ni1003

10.1038/nri1457

10.1073/pnas.0403342101

10.1073/pnas.0505802102

10.1073/pnas.1533209100

10.1002/eji.200526168

10.1016/S1074-7613(04)00110-4

10.1038/ni759

10.1016/S1074-7613(02)00280-7

10.1002/eji.200425818

10.4049/jimmunol.173.8.5008

10.4049/jimmunol.172.10.5823

10.1073/pnas.2334901100

10.4049/jimmunol.166.1.353

10.1016/S1074-7613(03)00327-3

10.1002/eji.200425810

10.1146/annurev.immunol.22.012703.104533

10.4049/jimmunol.173.2.1059

10.4049/jimmunol.176.3.1316

10.1038/ng927

10.1084/jem.20041538

10.1126/science.1078231

10.1093/intimm/dxh178

10.1084/jem.20042276

10.1093/intimm/dxh126

10.4049/jimmunol.173.11.6526

10.1084/jem.20040685

10.1038/nature02119

10.1126/science.1069057

10.1126/science.1069066

10.1084/jem.20041869

10.1084/jem.20050903

10.1093/hmg/11.4.397

10.1126/science.1075958

10.4049/jimmunol.174.4.1862

10.1084/jem.20050471

10.1038/ni906

10.1016/j.immuni.2005.07.005

10.4049/jimmunol.172.4.2067

10.1126/science.1105677

10.1002/eji.200535240

10.1038/nm960

10.3109/08916939908994073

10.4049/jimmunol.175.5.3025

10.4049/jimmunol.169.9.4712

10.4049/jimmunol.174.5.3111

10.1073/pnas.0404444101

10.1016/S0167-5699(98)01299-7

10.1016/S0167-5699(97)01217-6

10.1172/JCI200114235

10.1038/86283

10.1073/pnas.0507454102

10.1016/0092-8674(95)90348-8

10.1002/(SICI)1099-0895(199607)12:2<103::AID-DMR157>3.0.CO;2-2

10.1101/gr.412702

10.4049/jimmunol.174.7.4081

10.2337/diabetes.33.7.700

Penhale WJ, 1975, Thyroiditis in T cell‐depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocyte serum, Clin Exp Immunol, 21, 362

10.1084/jem.177.3.627

10.1016/S0952-7915(00)00163-1

10.1016/S1074-7613(01)00202-3

10.4049/jimmunol.171.8.4040

10.1006/jaut.1999.0272

10.1073/pnas.2235552100

10.4049/jimmunol.172.4.2651

Sakaguchi N, 1994, Ionizing radiation and autoimmunity. Induction of autoimmune disease in mice by high dose fractionated total lymphoid irradiation and its prevention by inoculating normal T cells, J Immunol, 152, 2586, 10.4049/jimmunol.152.5.2586

Morse SS, 1999, Virus and autoimmunity: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T cells, J Immunol, 162, 5309, 10.4049/jimmunol.162.9.5309

Sakaguchi S, 1994, Induction of autoimmune disease in mice by germline alteration of the T cell receptor gene expression, J Immunol, 152, 1471, 10.4049/jimmunol.152.3.1471

10.1002/eji.1830250139

10.1038/ng1323

10.1038/ng1673

10.1084/jem.20032158

Sullivan KE, 2002, CD4(+) CD25(+) T‐cell production in healthy humans and in patients with thymic hypoplasia, Clin Diagn Lab Immunol, 9, 1129

10.1016/S0140-6736(71)90057-2

10.1111/j.0105-2896.2005.00248.x